1 INDICATIONS AND USAGE Leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (RA). Leflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of adults with active rheumatoid arthritis.
zydus pharmaceuticals (usa) inc.
16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied
LEFLUNOMIDE tablets USP, 10 mg, white to off white, round, film-coated tablets debossed with "57" on one side and "11" on the other side, and are supplied as follow: NDC 70710-1157-3 in bottle of 30 tablets with child-resistant closure NDC 70710-1157-1 in bottle of 100 tablets with child-resistant closure NDC 70710-1157-5 in bottle of 500 tablets
LEFLUNOMIDE tablets USP, 20 mg, white to off white, triangular, film-coated tablets debossed with "58" on one side and "11" on the other side, and are supplied as follow: NDC 70710-1158-3 in bottle of 30 tablets with child-resistant closure NDC 70710-1158-1 in bottle of 100 tablets with child-resistant closure NDC 70710-1158-5 in bottle of 500 tablets Store at 20Â° to 25Â°C (68Â° to 77Â°F) [See USP Controlled Room Temperature]. Protect from light.
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site